October 21, 2026
A Delaware bankruptcy judge Wednesday gave the OK to artificial intelligence-powered pharmaceutical group BioXcel to proceed with a $125 million sale to Israeli drugmaker Teva Pharmaceuticals, and allowed the debtor to send its Chapter 11 plan for a creditor vote.
October 19, 2026
The U.S. Trustee's Office is urging a Delaware bankruptcy judge to reject AI-bolstered pharmaceutical group BioXcel's Chapter 11 plan disclosure statement ahead of a hearing Wednesday, arguing the plan contains nonconsensual third-party releases of claims that might be the only way unsecured creditors get paid back.
October 05, 2026
BioXcel Therapeutics' Chapter 11 filing paused a securities class action against it, a Delaware bankruptcy judge ruled Monday, after a federal court had pressed the life sciences group for a more detailed timeline on the final approval of a settlement in the litigation worth around $10 million.
September 28, 2026
A Delaware bankruptcy judge granted his approval Monday to the bidding procedures proposed in the Chapter 11 case of a company that uses artificial intelligence to explore new uses for existing drugs.
September 21, 2026
A Delaware bankruptcy judge approved employee retention and executive incentive payments that could total up to $3.2 million as AI-bolstered pharmaceutical group BioXcel works to sell its assets in Chapter 11.
September 08, 2026
A group of attorneys from Young Conaway Stargatt & Taylor LLP and Cooley LLP is representing artificial intelligence-powered drug company BioXcel Therapeutics Inc. in its Chapter 11 case.
September 01, 2026
A winery in California's Napa Valley struggling to recover from wildfires hit Chapter 11. A vertical farming startup whose products were distributed by a dozen supermarket chains was forced to liquidate. And a military contractor foundered after losing a crucial government agency as a client.
August 28, 2026
A company that uses artificial intelligence to explore new uses for existing drugs entered bankruptcy in Delaware with over $104 million in debt and a stalking horse bidder.